Terumo (OTCMKTS:TRUMY) Shares Gap Down – Should You Sell?

Shares of Terumo Corp. (OTCMKTS:TRUMY) gapped down prior to trading on Tuesday . The stock had previously closed at $15.50, but opened at $14.53. Terumo shares last traded at $15.04, with a volume of 3,307 shares traded.

Analyst Upgrades and Downgrades

Separately, Nomura raised Terumo from a “hold” rating to a “strong-buy” rating in a research note on Thursday, July 30th. One research analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Buy”.

Terumo Price Performance

The company has a debt-to-equity ratio of 0.06, a current ratio of 1.59 and a quick ratio of 0.97. The stock has a market cap of $22.07 billion, a P/E ratio of 21.08 and a beta of 0.68. The company’s 50 day simple moving average is $14.85 and its 200 day simple moving average is $13.94.

Terumo (OTCMKTS:TRUMY) last released its quarterly earnings results on Friday, August 7th. The company reported $0.30 EPS for the quarter, topping analysts’ consensus estimates of $0.17 by $0.13. Terumo had a return on equity of 10.55% and a net margin of 13.83%.The company had revenue of $1.97 billion for the quarter, compared to analyst estimates of $1.84 billion. As a group, equities analysts forecast that Terumo Corp. will post 0.7 earnings per share for the current year.

Terumo Company Profile

Terumo Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.